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Abstract 
BACKGROUND: Aquaporin (AQP) water channels are best known as passive 
transporters of water that are vital for water homeostasis. 
SCOPE OF REVIEW: AQP knockout studies in whole animals and cultured cells, 
along with naturally occurring human mutations suggest that the transport of neutral 
solutes through AQPs has important physiological roles. Emerging biophysical 
evidence suggests that AQPs may also facilitate gas (CO2) and cation transport. AQPs 
may be involved in cell signalling for volume regulation and controlling the 
subcellular localization of other proteins by forming macromolecular complexes. This 
review examines the evidence for these diverse functions of AQPs as well their 
physiological relevance.  
MAJOR CONCLUSIONS: As well as being crucial for water homeostasis, AQPs 
are involved in physiologically important transport of molecules other than water, 
regulation of surface expression of other membrane proteins, cell adhesion, and 
signalling in cell volume regulation. 
GENERAL SIGNIFICANCE: Elucidating the full range of functional roles of 
AQPs beyond the passive conduction of water will improve our understanding of 
mammalian physiology in health and disease. The functional variety of AQPs makes 
them an exciting drug target and could provide routes to a range of novel therapies.  
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1. Introduction 
The aquaporin (AQP) protein family is comprised of many small integral membrane 
proteins found in all phylogenetic kingdoms. There are up to 13 mammalian AQPs, 
which are found in most tissues with functions ranging from the regulation of renal 
water balance [1], brain-fluid homeostasis [2], triglyceride cycling between 
adipocytes and the liver [3] and structural integrity of the eye lens [4]. Because of 
this, understanding AQP function is crucial for the study of healthy ageing as well as 
the onset of many disease states such as brain swelling following stroke or head injury 
[5], nephrogenic diabetes insipidus [6, 7], cataracts [8], obesity [9], cancer cell 
proliferation and migration [10] and tumour angiogenesis [11]. Many of these 
functions and diseases involve either permeability of molecules other than water, or a 
function of the AQP other than facilitating membrane permeability.  
 
Thirteen human AQPs have been discovered to date; they range in size (before post-
translational modification) from 27 kDa (AQP8) to 37 kDa (AQP7) and, for those 
proteins for which single channel permeability has been quantified, have a 100-fold 
range in water permeability. A sub-set of these AQPs also function as channels for 
glycerol (and other solutes) and are referred to as (aqua)glyceroporins (GLPs). In 
humans, these are AQP3, -7, -9 and -10. AQP6 has also (controversially, see section 
4) been shown to be permeable to glycerol, although phylogenetically it is a member 
of the water-selective AQP subfamily [12]. It also is notable for its unusual 
permeability properties (activation by low pH and anion permeability) and 
intracellular localization. The permeability properties of the mammalian AQPs are 
summarized in Table 1. 
 
This review discusses how AQPs select and regulate the passage of solutes such as 
glycerol, urea and ammonia across cell membranes and the physiological relevance of 
this solute flow as well as putative functions of AQPs beyond facilitation of 
membrane permeability. 
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AQP 
Single channel water 
permeability (×10-14 
cm3s-1) 
 
Glycerol 
permeability 
 
Urea 
permeability 
 
Ammonia 
permeability 
AQP0 0.25 [13]; 
gated by calmodulin 
[14]; X, PL  
No [13]; 
X 
No [15]; 
X 
No [16]; 
X 
AQP1 6.0 [13]; 
X 
No [13]; 
X 
No [17]; 
X 
No [17]; 
X 
AQP2 3.3 [13]; 
X 
No [13]; 
X 
No [15]; 
X 
No [16]; 
X 
AQP3 2.1 [13]; 
X 
Yes [13]; 
X 
Controversial 
[15, 17-19]; 
X 
Yes [16, 17]; 
X 
AQP4 24 [13]; 
X 
No [13]; 
X 
No [20]; 
X 
No [16]; 
X 
AQP5 5.0 [13]; 
X 
No [13]; 
X 
No [21]; 
X 
No [16]; 
X 
 
 
AQP6 
Low pH and Hg2+ induce 
water permeability [22, 
23]. Basal permeability 
either is very low [23, 
24] or zero [25, 26]; 
X 
 
 
Yes** [26]; 
X 
 
 
Yes** [26]; 
X 
 
 
Yes [16]; 
X 
  
AQP7 
Permeable [27]; no 
quantitative data; 
X 
 
Yes [27]; 
X 
 
Yes [27]; 
X 
 
Yes [16]; 
X 
 
AQP8 
Permeable [28, 29]; no 
quantitative data; 
X, PL 
 
No [28, 29]; 
X, PL 
Controversial 
[28-30]; 
X, PL 
 
Yes [17, 31]; 
X, Y 
 
AQP9 
Permeable [32]; no 
quantitative data; 
PL 
 
Yes [17, 32]; 
X, PL 
 
Yes [17, 32]; 
X, PL 
 
Yes [17]; 
X 
 
AQP10 
Permeable [33]; no 
quantitative data; 
X 
 
Yes [33]; 
X 
 
Yes [33]; 
X 
 
Unknown 
AQP11 Permeable [34],~2 [35]*; 
M, V 
Yes** [36]; 
M 
Unknown Unknown 
AQP12 Unknown Unknown Unknown Unknown 
 
Table 1 – Water, glycerol, urea and ammonia (NH3) permeabilities of known human 
AQPs. Quantitative water permeability is per AQP channel i.e. after subtraction of 
the basal permeability of the expression membrane and normalized to the number of 
AQP molecules. Expression systems: X – Xenopus oocytes, PL – proteoliposomes, M 
– mammalian cells, V – vesicles derived from membrane fragmentation of AQP-
expressing mammalian cells, Y – ammonia transport deficient yeast. . *estimated from 
membrane fragment vesicle water permeability relative to AQP1-containing vesicles 
and relative expression level. **These data have not been independently replicated.  
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2. The structural biology of the AQP family is established 
There is a large amount of medium-to-high-resolution structural data available for the 
AQP family (43 structures deposited in the Protein Data Bank for 11 different AQPs). 
These structures suggest that the AQPs share many common structural features. The 
AQP monomer is composed of six tilted transmembrane (TM) helices that surround a 
central cavity containing two helix-forming loops that enter and exit from the same 
side of the membrane (see Figure 1A). This central cavity is the pathway for water 
and solute transport. The two helical loops contain highly conserved asparagine-
proline-alanine (NPA) motifs. Crystallography and molecular dynamics (MD) 
simulations suggest that the asparagine residues act, in concert with surrounding 
backbone carbonyl groups, to enable water transport by providing hydrogen bonds to 
water molecules [37], thereby lowering the free energy penalty (caused by breaking of 
water-water hydrogen bonds) of removing a water molecule from bulk solution. 
Recent biophysical experiments comparing AQPs with gramicidin and the potassium 
channel KcsA [38] suggest that the number of pore-lining hydrogen-bonding sites for 
water determines the channel water permeability. In addition to providing hydrogen-
bonding sites, the asparagine residues help to orient the water molecules such that the 
hydrogen atoms point ‘outwards’ from the pore, creating a barrier to proton transport 
[39]. A recent sub-angstrom crystal structure of the Pichia pastoris AQY1 found 
overlapping water densities in the pore that, supported by MD simulations, suggested 
a correlated pairwise movement of water molecules through the extracellular end of 
the pore. This correlated motion may help to minimise water-water hydrogen bonds in 
this region, providing a further barrier to proton permeation, without compromising 
water transport [37]. 
 
 Crystallographic analysis of the E. coli, GlpF (a GLP), suggests that the same 
asparagine residues also form hydrogen bonds with glycerol [40]. This is likely to be 
also true of other polar solutes that permeate GLPs. 
 
AQPs have intracellular amino (N-) and carboxyl (C-) termini of varying lengths; 
AQP8 has a short C-terminus of 10-15 residues, whereas AQP4 has a large C-
terminus consisting of ~70 residues. AQP11 has a large N-terminal tail of ~40 
residues, whereas AQPs 1,2 and 5 have short N-termini of <10 residues. In contrast to 
the structural conservation of the TM region of AQPs, much less is known about the 
structure of the termini. This is because the majority of AQP crystal structures are 
obtained using constructs in which the N- and C-terminal tails of the protein have 
been truncated due the difficulty of obtaining well-diffracting crystals using full-
length AQP molecules [41]. This suggests an inherent structural flexibility in these 
regions of AQP molecules and indeed a recent X-ray structure of AQP2, which 
included ~20 residues of the (truncated) C-terminal tail, found this fragment of the C-
terminus in four strikingly different conformations in each of the four AQP2 
monomers within the tetrameric unit cell [42]. 
 
AQPs are generally agreed to form tetramers [43-45] assembled around a central axis 
perpendicular to the plane of the membrane (see Figure 1B). A fifth, hydrophobic 
pore appears to form around this central axis with each of the monomers contributing 
one of the four ‘walls’ of the pore. The function, if any, of this fifth pore is not yet 
known, although postulated functions will be discussed in later sections. Some 
biochemical studies have suggested that tetramers formed by GLPs have reduced 
stability compared to tetramers formed by AQPs with strict water selectivity [46, 47]. 
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3. The principles of solute selectivity by AQPs remain to be 
established 
All AQPs (except AQP12, which has yet to be characterized) transport water (Table 
1), while some also transport glycerol. The glycerol permeable GLPs (e.g. human 
AQPs 7, 9 and 10) are also permeable to urea. The urea permeability of AQP3 is 
controversial, with some studies reporting urea transport and others no transport [15, 
17-19]. This may be due to methodological differences, and is discussed in detail in 
section 4.2.1. 
 
Of the mammalian GLPs AQP3, -7, and -9 are also permeable to ammonia. AQP8 is 
the only glycerol impermeable mammalian AQP that is permeable to ammonia 
(excluding 11 and 12, whose glycerol and/or ammonia permeabilities are currently 
unknown). The ammonia permeability of the most recently discovered member of the 
GLP group, AQP10, is still unknown. 
 
AQP11 and -12 are the most recently discovered members of the AQP family [48, 
49]; due to this and their localisation to intracellular membranes, non-water 
permeability experiments and functional studies have yet to be reported for AQP11 
and AQP12 respectively. There is one report that AQP11 increased the glycerol 
permeability of an adipocyte cell line [36], but this permeability of AQP11 has yet to 
be replicated. 
 
The ‘size exclusion’ model of AQP selectivity posits a correlation between the size of 
channel entrance and the permeability of the channel to different polar molecules. 
Notably, this model is based on in silico and crystallographic experiments, but 
minimal in vitro experiments; it is therefore unclear whether this model is broadly 
applicable to the AQP family as a whole. A conserved arginine residue (in the second 
helical loop directly after the NPA motif) forms part of a channel constriction known 
as the aromatic/arginine (ar/R) selectivity filter (see Figure 1A). In water-selective 
AQPs, the other components of this filter are a phenylalanine in the top half of the 
pore-facing side of transmembrane helix 2 (TM2) and a histidine in a similar position 
in TM5. In glycerol and urea permeable AQPs, this histidine is replaced by a small 
amino acid residue such as glycine (AQP3, -7, -10) or alanine (AQP9), although if the 
histidine is mutated to alanine in AQP1 it does not become a glycerol channel. If both 
aromatic members of the filter (H and F) are mutated to alanine, AQP1 functions as a 
urea channel and to a lesser extent as a glycerol channel [50]. Based on this 
observation and molecular simulations of AQP1 and the E. coli GLP, GlpF [50, 51], it 
has been suggested that the cross-sectional area of the pore at the ar/R region 
determines AQP selectivity for neutral polar solutes. Additionally, based on 
crystallographic analysis of GlpF and the bacterial water-selective AQP, AQPZ, it has 
been suggested that the positioning of the ar/R residues by the surrounding 
unstructured loops has a role in determining the channel size [52]. In AQP8, the only 
glycerol-impermeable, ammonia-permeable mammalian AQP, the third member of 
the filter is likely an isoleucine residue (based on sequence alignment), which is 
slightly larger than alanine or glycine. Overall, current thinking on solute selectivity 
suggests that the aromatic residues of the ar/R filter are important for solute exclusion 
in the water selective AQPs, but further molecular factors may be involved in 
mediating solute selectivity. 
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4. Physiological solute transport by AQPs 
4.1 Glycerol transport 
The movement of glycerol around the body is predominantly thought to include 
glycerol release from fat tissue through AQP7, entry into the liver through AQP9 and 
movement in the skin and kidneys through AQP3.  
 
4.1.1 AQP7 
AQP7 is expressed in adipose tissue in adipocytes [53] and capillary endothelia [54]. 
Upon hypoglycaemia, triglycerides are broken down within adipocytes to glycerol 
and free fatty acids [55]. Adrenaline, the plasma level of which is elevated upon 
hypoglycaemia, caused translocation of AQP7 from intracellular membranes to the 
plasma membrane [53]. Adrenaline signals through the 3-adrenergic receptor to 
initiate adipocytic lipolysis [56] making this the most likely link between adrenaline 
and AQP7 translocation although this has yet to be verified. Recent work has also 
suggested that AQP7 can be relocalized to lipid droplets by noradrenaline, possibly in 
a PKA dependent manner [57], raising the possibility of differential effects of 
lipolysis-inducing hormones on AQP7 localization. 
 
The glycerol liberated from triglyceride storage is released from adipocytes [58] and 
plasma glycerol becomes elevated. In AQP7 -/- mice, adipocyte plasma membrane 
glycerol permeability was reduced threefold [59]. Plasma glycerol levels in the fasting 
state and in response to 3-adrenergic agonist were reduced and adrenaline-induced 
glycerol secretion by cultured mouse adipocytes (differentiated 3T3-L1 cells) was 
reduced approximately two-fold [60]. These results suggest that the major pathway 
for glycerol efflux from adipocytes after lipolysis is AQP7.   
 
AQP7 -/- mice develop adipocyte hypertrophy and subsequent obesity in 
adulthood[59]. A loss of function mutation in the human AQP7 gene has been 
discovered (G264V) although this genotype was not correlated with obesity in 
humans [61]. This may be due to the presence of AQP10 in human adipocyte 
membranes, which was found to contribute ~50% of the water and glycerol 
permeability of healthy human adipocyte plasma membrane vesicles [62]. Mouse 
AQP10 is a pseudogene [63] and therefore this secondary route for glycerol efflux 
does not exist in mice. 
 
The serum concentration of glycerol in humans under normal physiological 
conditions is typically between 0.05 and 0.1 mM [64] and increases several-fold upon 
fasting (due to glycerol and free fatty acid liberation from adipose triglyceride 
storage) [65]. Glycerol is almost completely reabsorbed by the kidneys [66] (unless it 
is raised above ~0.3 mM[67]), suggesting the existence of a glycerol reabsorption 
pathway. AQP7 is expressed in the proximal tubule of the kidney. AQP7 -/- mice 
showed marked glyceroluria in comparison to wild type (~400-fold increase in urine 
glycerol) [68]. Human children homozygous for the AQP7 G264V mutant were found 
to have hyperglyceroluria, with a ~1000-fold increase in urine glycerol when 
compared to heterozygous familial controls [69]. The G264V mutant has been shown 
to have no activity as a glycerol or water channel in Xenopus oocytes [61], although 
plasma membrane expression was not verified in this study so that it could not 
differentiate between a non-functional channel and an incorrectly localised channel. 
The mutation disrupts a conserved GxxxG motif. These are important motifs for 
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transmembrane helix-helix interactions because they allow close contact between the 
backbone atoms of the two helices of an interacting pair [70]. It may be that the 
protein is incorrectly trafficked and localised in intracellular membranes due to an 
inability to form tetramers or an interaction required for membrane trafficking. 
Regardless of the loss of function mechanism, these data strongly suggest that AQP7 
is the TM glycerol reabsorption pathway in the renal proximal tubule. 
 
4.1.2 AQP9  
AQP9 is expressed in the liver [71], primarily in the hepatocytes with the strongest 
expression at the sinusoidal surface [72] (the liver sinusoids are continuous with the 
hepatic artery and portal vein). Upon fasting, glycerol released into the plasma from 
adipocytes is taken up by hepatocytes and used as a substrate for gluconeogenesis 
[73]. 
 
In rats, AQP9 protein expression is increased up to 20-fold after 24-96 hours fasting 
[32]. In mice, AQP9 expression measured in purified hepatocyte plasma membrane 
vesicles increased 10-fold after 18 hours fasting. This 10-fold increase was 
accompanied by a two-fold increase in hepatocyte plasma membrane glycerol 
permeability, which was reversed by addition of phloretin (an apple polyphenol that 
inhibits AQP9, AQP3 and several non-AQP membrane channel proteins including the 
SGLT1&2 glucose transporters and UT-A urea channels [74]). The increase was 
abolished in AQP9 -/- mice [75]. Fasted AQP9 -/- mice have elevated plasma glycerol 
compared to wild-type [75, 76]. In addition, plasma glucose concentration was 
decreased [76], indicating a gluconeogenetic deficiency. This data supports a 
physiological role for AQP9-mediated glycerol uptake by hepatocytes during fasting-
induced hypoglycaemia.  
 
Although the AQP9-mediated diffusion of glycerol into hepatocytes forms a sizeable 
proportion of the glycerol uptake in the fasting state (~50% in fasting mice), the fact 
that the membrane permeability to glycerol only doubles upon such a large increase in 
AQP9 expression suggests that there is also an AQP9-independent route for glycerol 
uptake. Whether this is directly across the lipid bilayer or through a phloretin 
insensitive glycerol channel is not clear. 
 
CD8+ (cytotoxic) T cells are white blood cells that facilitate the destruction of infected 
or otherwise damaged cells. During infection, antigen-specific CD8+ cells proliferate 
and differentiate into effector cells, which are involved in combatting infection. After 
pathogen clearance, most of the effector cells die and a small population remains as 
memory T cells, which can survive for decades [77]. In mouse memory cells, AQP9 
expression was upregulated post-infection via IL-7 signalling, allowing cells to import 
glycerol for triglyceride synthesis. AQP9 -/- T cells had reduced long-term survival 
compared to +/+ cells and the long-term survival of the +/+ cells could be inhibited by 
phloretin [78]. This suggests that AQP9 expression can act as a metabolic switch, 
enabling long-term survival of memory T cells by enabling triglyceride synthesis to 
build up an energetic reserve, allowing cell survival in nutrient poor conditions. 
 
Similarly to that seen in hepatocytes, intracellular glycerol in CD8+ T cells was 
reduced by ~50% in the AQP9 -/- cells, again suggesting a secondary route for 
glycerol uptake. 
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4.1.3 AQP3 
AQP3 is expressed in the skin in keratinocytes below the stratum corneum (SC). It is 
most strongly expressed at the plasma membrane in these cells with some intracellular 
labelling reported in cells of the basal layer [79]. The ability of the epidermis to 
maintain hydration is impaired in AQP3 -/- mice. In dry conditions, AQP3 -/- mice 
showed comparable (reduced) levels of SC hydration to wild-type mice, whereas at 
normal humidity, SC hydration was lower in the AQP3 -/- mice [80]. Elevated 
humidity (which prevents water loss via evaporation) did not correct the deficiency, 
which suggests that the primary role of AQP3 in skin hydration is not to provide 
water to replace that lost by evaporation.  
SC glycerol concentration in AQP3 -/- mice is reduced to ~40% of that of wild-type, 
with no significant difference in the levels of other osmolytes (ions, glucose, urea, 
lactate and free amino acids) [81]. Glycerol acts as a humectant (a ‘water-retaining’ 
osmolyte), which may be the mechanism by which it maintains skin hydration. It has 
also been suggested that glycerol may prevent SC water loss by inhibiting the phase 
transition of intercellular lipids from the liquid crystalline to the solid phase [82] due 
to the fact that breaks in a solid crystal lattice increase the water permeability in in 
vitro models of the SC intercellular lipid barrier [83]. The rate of transport of glycerol 
from blood to the SC was reduced in AQP3 -/- mice resulting in reduced lipid 
biosynthesis[84]. This suggests a further role for glycerol in maintaining skin 
hydration by allowing the maintenance of the SC lipid barrier. 
 
Further evidence for the role of AQP3-mediated glycerol transport is provided by the 
fact that topical or systemic administration of glycerol was found to correct the skin 
deficiencies in AQP3 -/- mice [84].  
 
4.2 Urea transport 
Urea is produced in the liver (as a non-toxic carrier of waste nitrogen) from ammonia, 
which is a neurotoxic product of protein degradation. Ammonia causes cell death of 
astrocytes by stimulating the mitochondrial permeability transition [85] (opening of 
promiscuous mitochondrial membrane channels that leads to apoptosis or necrosis, 
depending on cellular ATP availability [86]), although the mechanism by which this 
happens is not clear. An adult human excretes about 25 g/day of urea in the urine, and 
urea transport in the kidney is vital for the urinary concentrating mechanism [87]. The 
physiological roles of urea transport by AQPs are less clear than those of water and 
glycerol transport.  
 
4.2.1 Which mammalian AQPs are urea channels? 
AQPs 7 [27], 9 [88] and 10 [33] have been shown to be urea permeable and there is a 
consensus in the literature on the urea permeability of these AQPs. For example, 
AQP9 is a urea channel in the liver expressed in hepatocytes at the sinusoidal surface. 
Urea permeability measurements performed on mouse hepatocyte plasma membrane 
vesicles of AQP9 -/- and urea transporter type A1/3 (UT-A1/3) -/- mice showed that 
AQP9 contributes ~30% to mouse hepatocyte membrane permeability and a 
member(s) of the UT-A family contributes ~40%[91]. However, AQP9 -/- mice did 
not demonstrate any deficiency in urea clearance from hepatocytes in a state that 
promotes elevated hepatic urea production (high protein diet), suggesting that AQP9 
and UT-A provide redundant pathways for urea transport from hepatocytes to the 
blood.  
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However, there is conflicting evidence in the literature on whether AQPs 3 and 8 are 
urea channels. Early work on AQP3 suggested that rat AQP3 was urea permeable, 
with expression of AQP3 in Xenopus oocytes increasing urea uptake twofold after 30 
minute incubations of oocytes with radiolabelled urea [89] or threefold in oocyte 
swelling assays [18]. Further studies on rat AQP3 found no urea transport using 
similar oocyte volumetric techniques [15, 17]. These studies differed in that the 
former used 165 mM urea whereas the latter two used 20 mM urea. It may be that 
AQP3 urea transport is so slow that at 20 mM it does not induce large enough volume 
changes to be measured on the timescale of an oocyte swelling experiment (~1 min), 
or that the transport is non-linear, although this seems unlikely given the linear nature 
of water and glycerol transport by AQP3 [90]. 
 
In one study, human AQP3 was used a positive control for AQP urea permeability. 1 
mM of urea was added to AQP3-expressing oocytes and after a 10 minute incubation, 
the oocytes had an intracellular urea concentration of ~75 μM (assuming an oocyte 
volume of 1 μL) [19]. This is ~10% of the expected equilibrium value, and the fact 
that it is still so far from equilibrium even after 10 minutes suggests that urea 
transport through AQP3, whilst non-zero, is very slow. This may explain the different 
results between short (typically ~1 min) volumetric experiments and the longer 
timescale radiolabelled solute uptake experiments.  
 
Early work on mouse AQP8 suggested that it was urea permeable [30], whereas rat 
AQP8 was not [29], both using radiolabelled solute uptake measurements in Xenopus 
oocytes. Work on purified rat, mouse and human APQ8 in proteoliposomes suggested 
that neither rat nor human AQP8 were urea permeable [28]. This study did not report 
mouse urea permeability due to liposome swelling discrepancies, probably caused by 
the ionic detergent required to solubilize mouse AQP8.  
 
There is considerable interspecies amino acid sequence variability for AQP8 (e.g. 
74% identity between human and mouse AQP8, c.f. 94% for AQP1 and 93% for 
AQP4). Interestingly, one difference between human and mouse AQP8 is a residue 
that is predicted to be pore-lining (based on a homology model to bovine AQP0 [28]) 
and situated at the ar/R filter, G207 (in human; A205 in mouse). The idea of species-
specific differences in permeability of AQP8 is intriguing, but studies performed in 
parallel in the same experimental system are required to validate this. 
 
4.3 Ammonia transport 
Ammonia is produced as a by-product of protein breakdown and quickly converted to 
urea via the hepatic urea cycle to prevent ammonia neurotoxicity. It is important for 
control of acid-base balance in the kidney, where ammonia synthesis and excretion 
are tightly regulated and change in response to acid- or alkalosis [92]. 
Members of the GLP subfamily, AQPs 3 [17], 7 [16] and 9 [17], have been reported 
to be permeable to ammonia, as has AQP8 [17, 93]. There is also evidence of 
ammonia permeability of AQPs 1, 6 and 7 using microelectrode measurements of 
oocyte surface pH[16]. The physiological relevance of ammonia permeability of 
AQPs is unclear. 
 
AQP8 -/- mice have only the very mild phenotypic abnormality of slight 
hypertriglyceridaemia after three weeks on a high (50%) fat diet [94]. AQP8 is 
expressed in the inner mitochondrial membrane of hepatocytes [95] and increased the 
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transport of an ammonia analogue into AQP8-expressing S. cerevisiae and rat 
hepatocyte mitochondria by three-fold. However, AQP8 -/- mice do not show any 
impairment in ammonia clearance under physiological conditions or when chronically 
or acutely loaded with ammonia [96]. This suggests a secondary (non-AQP) pathway 
for ammonia, which either provides the majority of ammonia permeability in these 
tissues, or is up-regulated in ammonia-permeable AQP knockouts. The proteins 
associated with the Rhesus (Rh) blood group system have been shown to function as 
ammonia channels [97]. Several of these are expressed in the liver [98] (RhB and 
RhC) and the kidneys (again RhB and RhC), where ammonia has an important role in 
acid-base balance [99]. Rh -/- mice have been generated, however these studies have 
focused on the erythrocytic Rh proteins [100, 101]. Phenotype analysis of RhB and 
RhC -/- organisms and double AQP/Rh knockouts could provide an answer. 
Knockdown of AQP8 in primary rat hepatocytes by ~80% reduced ammonium 
chloride-induced ureagenesis by 30% and abolished glucagon-stimulated increases in 
ureagenesis [102]. AQP8 knockdown in a human proximal tubule cell line decreased 
the rate of ammonia excretion by 31% at pH 7.4 and by 90% at pH 6.9 [103], 
suggesting that AQP8 ammonia permeability might be required for renal ammonia 
excretion and be involved in the renal adaptive response to acidosis. Furthermore, 
acid-induced downregulation of AQP8 by 30% in primary rat hepatocytes was 
correlated with a 31% reduction in hepatocyte ureagenesis, and AQP8 downregulation 
was correlated with reduced liver urea content in rats subjected to seven days of 
acidosis [104]. These data support the idea of a physiological role for AQP8 in either 
plasma membrane diffusion of ammonia, mitochondrial ammonia transport, or both in 
support of renal and hepatic ammonia handling.  
 
AQP3 -/- mice have several physiological abnormalities including reduced skin 
elasticity [80] and polyuria [105], but these can all be explained in terms of reduced 
glycerol and water permeability, so it is unclear whether AQP3 ammonia permeability 
has any physiological function.  
 
AQP7 is present in adipocytes. It has been shown in humans that during intense 
exercise, adipose tissue removes ammonia from the plasma and increases its 
glutamine/glutamate ratio[106], suggesting incorporation of ammonia into glutamine 
through glutamine synthase as a secondary detoxification pathway in support of the 
hepatic urea cycle at times of elevated plasma ammonia. Whether AQP7 contributes 
to this ammonia uptake is yet to be investigated. 
 
4.4 Carbon dioxide transport 
The majority of carbon dioxide (CO2) produced by cellular metabolism (~70%) is 
transported to the lungs for expulsion from the body via the bicarbonate (HCO3
-) 
system. Briefly, carbon dioxide diffuses out of the cells in which it is produced and 
into the plasma. It moves down its concentration gradient into erythrocytes (red blood 
cells), where carbonic anhydrase catalyses conversion into carbonic acid. Upon 
dissociation (H2CO3H+ + HCO3-), the HCO3- ion is exchanged across the 
erythrocyte membrane for a chloride ion and the proton binds to haemoglobin [87]. 
 
There has been speculation that CO2 transport across the plasma membrane of 
erythrocytes might be aided by channel proteins [107, 108]. There is conflicting data 
on whether an AQP contributes to this potential CO2 pathway. AQP1 is expressed at 
the plasma membrane of erythrocytes [109]. Human AQP1 has been reported to 
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increase the CO2 permeability of Xenopus oocytes four-fold in the presence of 
carbonic anhydrase suggesting that AQP1 functions as a CO2 channel [110]. Further 
work ruled out the possibility of AQP1 increasing the oocyte membrane permeability 
by altering local lipid composition or structure, interaction between AQP1 and 
carbonic anhydrase or up-regulating a native CO2 channel by use of a mercurial 
AQP1 inhibitor (pCMBS) and the AQP1 C189S mutant, which is insensitive to 
mercury [111].  
 
AQP1 -/- human erythrocytes (Colton-null cells) retain HCO3
- permeability, but have 
a 60% reduction in CO2 permeability when compared to human erythrocytes 
expressing AQP1 (i.e. not Colton-null) [112]. However, the CO2 permeability of 
AQP1 -/- mouse erythrocytes from AQP1 knockout mice was not different to wild-
type [113]. 
 
Stopped flow experiments with AQP1 reconstituted into liposomes have also given 
conflicting results. AQP1 from human blood increased the CO2 permeability of 
liposomes four-fold[114], whereas mouse AQP1 showed no increase[113]. This 
agrees qualitatively with the results from measurements on intact erythrocytes in that 
human AQP1 appears to increase CO2 permeability of the membrane, whereas mouse 
AQP1 does not. This may be due to methodological differences, but it also raises the 
intriguing possibility that human AQP1 is CO2 permeable whereas mouse AQP1 is 
not. 
 
It is possible that if CO2 permeates AQP1, it does so through the central tetrameric 
pore rather than the monomeric water pore. Molecular dynamics simulations using a 
variety of enhanced sampling methods and unbiased simulation consistently suggest 
that the free energy barrier to permeation of the central, hydrophobic pore of AQP1 is 
considerably smaller than the barrier to permeation of the water pores [115-117], 
probably due to the water-protein hydrogen bonds at the selectivity filter and NPA 
sites that need to be disrupted in order for a CO2 molecule to traverse the water pore. 
Simulation of model bilayers suggest that the free energy barrier for passage of CO2 
directly across the membrane is much smaller than for permeation through AQP1, and 
in this kind of system, AQP expression would probably serve to decrease the CO2 
permeability by reducing the surface area available for diffusion directly across the 
membrane [115, 116]. However, it is not clear how good of a model a single species 
phospholipid bilayer is for a cellular membrane. It is possible that a simulated bilayer 
containing a mixture of lipid species along with sterols would display different 
resistance to CO2 passage, and biophysical measurements of CO2 diffusion into 
artificial lipid vesicles showed that addition of cholesterol could reduce membrane 
CO2 permeability by up to 100-fold [118]. This agrees qualitatively with MD 
simulations that include cholesterol [119]. In addition to CO2, MD simulations have 
also suggested that the central pore could be permeable to molecular oxygen [115] 
and there is some evidence that AQP1 overexpression could accelerate cellular 
hypoxia [120], although whether this was a direct or indirect effect was not clear. 
 
It seems apparent that AQP1 can conduct CO2 (possibly along with AQP 0, 5, 6 and 9 
and the M23 isoform of AQP4 [16]), however the physiological relevance (if any) of 
AQP CO2 permeability is yet to be demonstrated. There is also a similar debate in the 
plant AQP field on whether AQPs might contribute to regulating CO2 levels for 
photosynthesis [121]. A recent review dedicated to AQPs and CO2 permeability of 
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biological membranes [122] concluded that “the debate about the mechanism of 
membrane CO2 diffusion continues and it is difficult to draw general conclusions”. 
This is still very much an open question. 
 
4.5 Hydrogen peroxide transport 
Superoxide (O2
-) molecules are produced in the mitochondria as a by-product of ATP 
synthesis (particularly by complexes I and III in the electron transport chain) and by 
the NADPH oxidase (NOX) family of enzyme complexes, which couple intracellular 
oxidation of NADPH to extracellular production of superoxide (O2
-) molecules. High 
levels of reactive oxygen species (ROS) derived from these pathways are well known 
to cause cellular damage and even death and mitochondrial ROS were long 
considered to be purely harmful by-products of an imperfect metabolic system. 
However, work in the last decade has shown that they are crucial for a variety of 
physiological processes including adaptation to hypoxia, immune function and 
regulation of autophagy (probably mediated by redox modification of cysteine 
residues) [123], so clearly there is a need for tight regulation of ROS levels. 
Superoxide undergoes disproportionation to molecular oxygen and hydrogen peroxide 
(H2O2), which can be catalysed by the enzyme superoxide dismutase [124], and the 
highly reactive H2O2 can then go on to form a variety of further ROS.   
 
H2O2 and H2O have similar molecular sizes, dipole moments and hydrogen bonding 
capacities [125], therefore it would not be surprising to find that some AQPs could 
transport H2O2. The half-life for H2O2 in cells is very short (e.g. ~1 ms in 
lymphocytes [126]), making biophysical experiments of the kind used for e.g. 
glycerol or urea permeation very difficult. Growth assays using H2O2 transport-
deficient yeast are typically used, and reduced growth after expression of an AQP is 
interpreted as an AQP-mediated increase in membrane H2O2 permeability causing 
cellular damage and/or metabolic disruption. Using this technique, human AQP8, rat 
(but not human) AQP1 and several mutants thereof were shown to be H2O2 permeable 
[127]. Based on this data, the authors suggested that all AQPs function as H2O2 
channels. It is not clear whether this is a valid generalization, but clearly some 
mammalian AQPs are H2O2 channels. 
 
Imaging studies using a novel H2O2 sensitive fluorescent dye in transiently transfected 
HEK293 cells demonstrated H2O2 permeability for human AQP8 and AQP3 (but not 
AQP1). Furthermore, AQP3 overexpression in HeLa cells allowed the cells to 
respond to serum starvation via ROS mediated activation of the AKT (protein kinase 
B) signalling pathway, whereas cells not expressing AQP3 could not. Knockdown of 
AQP3 in a colon cancer cell line inhibited the AKT response to epidermal growth 
factor (EGF) [128], which can initiate ROS signalling via activation of NOX 
complexes. This suggests that AQP3 is required for uptake of NOX-generated H2O2 
in EGF signalling. 
 
T cell migration along chemokine gradients is vital for correct immune responses. T 
cells from AQP3 -/- mice had 40-60% reductions in migration distance in response to 
a variety of chemokines and had a ~50% reduction in chemokine-induced 
transendothelial migration. Activation of Cdc42, a small GTPase involved in 
cytoskeletal reorganization associated with chemotaxis, was completely inhibited in 
the AQP3 -/- cells. Treatment with extracellular catalase, which catalyses H2O2 
breakdown to H2O and O2, prevented the Cdc42 response in AQP3 +/+ cells and 
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treatment with high concentration (100 μM) of exogenous H2O2 recovered both the 
Cdc42 response and the T cell migration in AQP3 -/- cells [129]. Together, these data 
suggest that AQP3 is required for uptake of extracellular H2O2 (probably NOX-
generated) in the T cell chemotactic response. 
 
Intracellular ROS levels can be elevated in leukaemia cells and NOX-derived ROS 
can activate leukaemia cell survival pathways. In a leukaemia cell line, shRNA-
mediated knockdown of AQP8 reduced and overexpression increased intracellular 
H2O2 content as well as H2O2 uptake after 10 mins in 100 μM H2O2. Furthermore, 
cellular glucose uptake and proliferation were correlated with intracellular H2O2 and 
AQP8 expression [130], suggesting that AQP8 can facilitate increased metabolism 
and proliferation in leukaemia. 
 
AQP8 is also expressed in inner mitochondrial membranes (IMM) in hepatocytes. 
Knockdown of AQP8 by 60% using siRNA in a hepatocyte cell line caused a twofold 
increase in mitochondrial ROS concentration and a 45% decrease in H2O2 output in 
isolated mitochondria. This was correlated with an 80% depolarization of the 
mitochondrial membrane, which was reversible by cyclosporin A (an inhibitor of the 
mitochondrial permeability transition) or a mitochondrial antioxidant, and a ~30% 
reduction in cell viability [131]. This suggests that AQP8-mediated H2O2 release from 
hepatic mitochondria acts as a mechanism to minimize mitochondrial oxidative stress. 
 
AQP11 is localized to the ER in the renal proximal tubule. The C227S mutation of 
AQP11 caused proximal tubule injury and eventual renal failure in mice [132]. Mice 
heterozygous for the AQP11 C227S mutant were predisposed to glucose-induced 
accumulation of ROS in the proximal tubule and reduction of kidney function. 
Inhibition of glucose uptake by the non-specific inhibitor phlorizin or antioxidant 
(sulforaphane) treatment was able to protect kidney function. This effect was 
reproduced in a proximal tubule cell line, in which siRNA-mediated knockdown of 
AQP11 increased intracellular ROS concentration twofold in the absence of glucose 
and fourfold in the presence of glucose [133]. It is not clear whether AQP11 was 
controlling intracellular ROS accumulation by acting as an ER H2O2 channel, or 
whether this was an indirect effect. 
 
Taken together, these examples provide clear evidence for AQP-mediated H2O2 
membrane permeability and suggest physiological roles in redox signalling via uptake 
of NOX-derived H2O2 and in cellular mechanisms for minimizing oxidative stress. 
 
A recent review of H2O2 permeability of AQPs suggested that rat AQP1 may be 
permeable to H2O2 whereas human AQP1 is not [134]. The authors of the cited study 
[127] suggest that the difference is due to differences in plasma membrane 
localization, although surface expression was not measured directly. This difference is 
particularly interesting given the speculation that we made regarding differences in 
CO2 permeability between human and mouse AQP1 and the possible differences in 
AQP8 urea permeability between species and raises the important point that despite 
high levels of conservation between AQPs from different mammals, they are not 
exactly the same proteins (e.g. rAQP1 and hAQP1 differ by 18 residues), and direct 
comparison between AQPs from different mammals in different experimental systems 
may not always be appropriate. 
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5. The physiological role of AQP6: An unusual AQP 
AQP6 is expressed primarily in kidney epithelia, where it is expressed only in 
intracellular membranes. Immunostaining was observed in podocyte intracellular 
vesicles, sub-apical vesicles in straight proximal tubule cells, and in both sub-apical 
and sub-basolateral domains within type A (acid-secreting) intercalated cells in the 
collecting duct[135]. 
 
AQP6 has low intrinsic water permeability: The membrane water permeability of 
Xenopus oocytes expressing AQP6 was increased less than threefold [22, 136], and in 
some experiments, not at all [25, 26]. In contrast to other members of the AQP family, 
mercury increases rather than inhibits AQP6 water permeability, which is reversibly 
increased approximately tenfold upon HgCl2 application. Low pH activated a 
reversible anion permeability of AQP6 [22] which was also shown to be ~tenfold 
more permeable to nitrate than chloride [137]. In rat collecting duct, intercalated cells, 
AQP6 co-localises with H+-ATPase in intracellular vesicles [22], and in the 
intercalated cells of alkali-loaded rats, AQP6 mRNA and protein levels increased 
after a week [138]. These results, along with the pH-activation of AQP6 water and 
anion permeability suggest involvement of AQP6 in acid-base balance in the renal 
collecting duct. However the lack of in vivo experiments with AQP6 knockouts or 
naturally occurring mutations precludes any meaningful conclusions about the 
physiological roles of AQP6. 
 
6. Ion permeability of AQPs: An unresolved controversy 
AQPs support bulk movements of fluid by giving high water permeability to 
membranes that secrete osmolytes. These osmolytes are often ions (e.g. Na+, K+ and 
Cl-) and this is reflected in the fact that several AQPs form macromolecular 
complexes with ion channels and transporters [41]. Perhaps a more efficient way for 
nature to achieve this dual permeability would be to have both ions and water pass 
through the same channel. Indeed it has been observed that several ion channels can 
transport water [38], but it has also been suggested that some AQPs may function as 
ion channels.  
 
The pH-sensitive ion permeability of AQP6 is well established, and it is likely that the 
monomeric pore is the ion pathway given that a point mutation to a pore-lining 
residue of AQP6 abolished ion permeability [137] and AQP6-mimicking mutations of 
a pore-lining amino acid residue of AQP5 conferred anion permeability [139]. There 
is also some evidence that the plant AQP nodulin-26 from soybean can act as a 
voltage-gated, anion-biased ion channel [140, 141]. 
 
More controversial is the idea that the fifth pore formed at the fourfold axis of the 
tetramer of AQP1 may function as a cation channel. In Xenopus oocytes, heterologous 
expression of human AQP1 led to a PKA-activated cation permeability probably 
mediated by phosphorylation of AQP1 [142] and a cGMP-activated cation 
permeability via direct binding of cGMP to the C-terminus of AQP1 [143]. PKC 
activity was shown to increase the cation permeability of AQP1 in Xenopus oocytes 
via direct phosphorylation of AQP1 at residues T157 and T239 [144]. We recently 
showed that phosphorylation at these sites by PKC is required for trigger-induced 
translocation of AQP1 to the plasma membrane [145], so this may represent more 
AQP1 molecules in the membrane rather than an increase in the cation permeability 
or open probability of a single channel. Phosphorylation of a tyrosine residue (Y253) 
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in the C-terminal tail of AQP1 was recently shown to be required for activation by 
cGMP [146]. The cGMP-activated cation current was verified for purified AQP1 in 
planar artificial membranes and the AQP1 water permeability inhibitor pCMBS did 
not inhibit ion permeation, suggesting that the water and ion pathways through AQP1 
are not the same[147]. Furthermore, point mutations to residues lining the tetrameric 
pore altered conductance properties [146]. The open probability was found to be very 
small (<10-6) in the planar bilayer system [147], which raises doubts over the 
physiological relevance of this cation conductance. This study suggested that this very 
low probability could reflect a misfolding or protein degradation artifact rather than a 
“real” function of AQP1. Furthermore, human APQ1 expressed in HEK293 cells did 
not induce an above-background cation conductance when cells were loaded with 
either cGMP or analogues thereof [148]. Additionally, after the initial report of AQP1 
cation permeability by Yool et al, several laboratories reported being unable to 
replicate this result in the same experimental system (and in some cases, with exactly 
the same AQP1 construct) [149]. High variability in oocyte response to forskolin was 
also reported. It was suggested that the discrepancy could be due the protocol for 
choosing ‘healthy’ oocytes on which to perform experiments. A cut-off for oocyte 
membrane potential is routinely used for this. Yool et al choose oocytes with a 
potential < -20 mV, whereas others used a -35 mV cut-off. If AQP1 does indeed act 
as a cation channel it is plausible that it could cause a slight depolarization, leading to 
oocytes in which AQP1 is acting as an ion channel to be falsely excluded as 
unhealthy.   
 
Rat choroid plexus cells, which strongly express AQP1, were found to have a cGMP-
activated cation conductance that was abolished by treatment with AQP1 siRNA. 
Activation of the current by atrial natriuretic peptide (ANP), which signals through 
guanylate cyclase, inhibited basal-to-apical fluid transport. The contribution of AQP1 
to this inhibition was not confirmed directly, although Cd2+, which was shown to 
inhibit cGMP-induced cation conduction of AQP1, reversed the inhibition of fluid 
transport [150]. ANP and a cGMP analogue were also shown to upregulate apical-to-
basal fluid transport in cultured retinal pigment epithelial cells, but this was reversed 
by an inhibitor of AQP1 water permeability [151]. 
 
It is clear that, under the right set of circumstances, AQP1 can act as a cation channel, 
with the ion pathway probably residing in the central pore formed by tetrameric 
assembly. Whether or not this ion conductance has physiological relevance remains 
an open question. However, coupled water and ion movement are vital for several 
pathophysiological processes including tumour angiogenesis and cell migration [152] 
and epilepsy [153], so it remains an intriguing possibility that AQPs are performing a 
dual function. 
 
7. Cell Volume Regulation by AQPs 
Many cells have the ability to modulate their physical size. This is achieved by the 
import or export of osmolytes in order to move water into or out of the cell by 
osmosis. Regulatory cell volume decrease (RVD) is mediated by potassium chloride 
and taurine efflux and regulatory cell volume increase (RVI) by sodium influx [154]. 
AQPs play a role in mediating the osmotic water movement in cell volume regulation 
[155], but there is some evidence that their role may go beyond acting as a passive 
water pore. 
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The stretch-activated transient receptor potential vanilloid type 4 (TRPV4) channel is 
a Ca2 +-biased non-selective cation channel (NSCC) that is activated by cell 
swelling[156] and has been implicated in cellular responses to osmotic stimuli[157]. 
In some cell types TRPV4 has been shown to provide a Ca2 + signal that is correlated 
with activation of the K+ and Cl− channels responsible for the decrease in cellular 
osmolality associated with RVD [157, 158]. In human and murine salivary gland 
cells, TRPV4 has a functional interaction with AQP5; in AQP5 knockout cells, the 
hypotonicity-induced calcium influx through TRPV4 was attenuated and subsequent 
RVD was abolished. Hypotonicity also increased cell surface expression of both 
TRPV4 and AQP5 and increased their co-localisation [159]. This suggests a role for 
AQP5 in the regulation of TRPV4 surface expression or hypotonicity-induced 
activity. 
In another example, the RVD of sperm of AQP3 −/− mice was inhibited compared to 
wild-type mice and the mice displayed reduced fertility[160] [161]. Upon entry into 
the female reproductive tract, sperm normally encounter a decrease in extracellular 
osmolality, which is thought to be the signal that activates sperm motility[160]. 
However, this hypotonic stress also causes cell swelling which, if left uncorrected by 
RVD, leads to impaired fertilisation, likely due to excessive bending of the sperm tail 
inside the uterus [161]. If AQP3 was simply acting passively as a water channel, RVD 
would not be abolished in AQP3 −/− sperm but rather the timescale on which the cell 
reaches osmotic equilibrium would be increased. A possible explanation for reduced 
fertility and altered RVD in AQP3 −/− mice is therefore that AQP3, either alone or as 
part of a macromolecular complex which is disrupted by AQP3 knockout, is involved 
in the signalling pathway that activates RVD in sperm. 
In a further example, when exposed to a hypotonic extracellular solution, cultured 
renal cortical collecting duct (CCD) cells, which do not endogenously express AQP2, 
swelled in proportion to the change in extracellular osmolality but did not exhibit 
RVD. However, when transfected with AQP2, these cells showed an RVD of 
approximately 40%. Shrinkage was mediated by Ca2 + influx through TRPV4, which 
activated Ca2 +-dependent K+ and Cl− channels and Ca2 +-dependent Ca2 + release from 
intracellular stores. In renal CCD cells expressing AQP2, hypotonic stress caused 
translocation of TRPV4 to the plasma membrane. This response did not occur in 
AQP2-negative cells. When TRPV4 was pre-translocated to the cell surface prior to 
hypotonic exposure, RVD was recovered in AQP2-null cells, showing that it is not 
simply the high water permeability of AQP2 that allows RVD. However, there did not 
appear to be any co-localisation between endogenous TRPV4 and overexpressed 
AQP2 in this system, either before or after hypotonic shock, indicating a functional 
rather than physical interaction [162]. These observations suggest that AQP2 forms 
part of a sensory and signalling pathway that results in TRPV4 translocation, possibly 
via sensing of extracellular osmolality.  
In a nasopharyngeal cancer cell line, swelling-induced chloride currents could be 
inhibited by siRNA-mediated knockdown of AQP3, extracellular application of CuCl2 
(a non-specific AQP3 inhibitor) or injection of AQP3 antibodies via recording 
pipettes. AQP3 also co-immunoprecipitated with the ClC3 chloride channel in this 
system [163]. The effect of the current-inhibiting treatments on AQP3-ClC3 
interaction or ClC3 subcellular localization was not investigated, but this data 
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suggests a role for AQP3 in RVD chloride efflux in these cells, possibly mediated via 
activation or localization of the ClC3 chloride channel. 
It has been suggested that AQPs could act as direct sensors of osmotic gradients by 
coupling conformational changes of the protein to a pressure gradient within the pore 
[164]. This argument relies on the idea of the hydrostatic pressure within the pore and 
it is not clear that the application of classical fluid mechanics is applicable to a system 
typically consisting of <10 water molecules. Nonetheless it is an intriguing idea, and 
taken together, these examples clearly support the idea of a signalling or sensory role 
for AQPs in cell volume regulation beyond a passive water conduction mechanism. 
8. Regulation of membrane protein localization by AQPs 
There is some evidence that the expression of one AQP can regulate the expression, 
localization or membrane trafficking of other AQPs and of other membrane proteins. 
 
AQP3 -/- mice have polyuria and a urinary concentrating defect. In the cortical 
collecting ducts of knockout mice, apical AQP2 expression was reduced compared to 
controls and basolateral AQP4 localization was completely absent. In contrast, 
medullary collecting duct levels of both AQP2 and AQP4 was not different between 
wild-type and AQP3 -/- mice [105]. This may reflect a requirement of AQP3 for 
expression or trafficking of AQPs 2 and 4 in certain cell types, although these 
observations could also be due to regulation of AQPs 2 and 4 in response to the 
polyuria phenotype. 
 
AQP11 -/- mice develop polycystic kidney disease (PKD). In AQP11 -/- mice, 
polycystin 1 (PC1), a protein to which loss of function mutations are associated with 
autosomal dominant PKD, was upregulated twofold. However, the plasma membrane 
localization of PC1 was almost completely abolished and PC1 was differentially 
glycosylated in the AQP11 -/- mice compared to AQP11 +/+ [165]. Glycosylation of 
some membrane proteins is a crucial step in protein folding and passage through the 
ER quality control system [166]. Other membrane proteins (AQP1 and PC2) were 
correctly glycosylated, suggesting that this was a PC1 specific effect. This data 
suggests that AQP11 can regulate the surface expression of PC1, possibly by 
mediating an interaction with a glycosyltransferase or part of the ER quality control 
system. 
 
The interactions between the stretch-activated cation channel TRPV4 and both AQP2 
and AQP5 has been discussed in section 6. Briefly, expression of these AQPs was 
required for the hypotonicity-induced translocation of TRPV4 to the plasma 
membrane associated with RVD [159, 162]. It may be that in these systems, AQPs 
and TRPV4 are present in the same vesicles, but the trafficking machinery interacts 
only with the AQP. We have recently described hypotonicity-induced translocation of 
AQP1 in HEK293 cells [145] and AQP4 in primary rat astrocytes [167], so this may 
reflect a general regulatory mechanism by which AQPs can mediate the subcellular 
localization of other membrane proteins. 
 
The histone methyltransferase Dot1a was shown to inhibit the expression of AQP5 in 
murine renal cells. Knocking out Dot1a led to AQP5 expression in these cells. The 
total level of AQP2 expression was unchanged in the presence of AQP5, but AQP2 
membrane trafficking was impaired. In addition to this, co-transfection of AQP5 and 
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AQP2 into IMCD3 cells reduced AQP2 surface expression compared to transfection 
of AQP2 alone, suggesting that AQP5 can regulate AQP2 localization. Furthermore, 
AQP2 and AQP5 co-immunoprecipitated with one another, suggesting a direct 
physical interaction [168]. The stoichiometry of the AQP2/AQP5 complexes was not 
investigated, so it is not clear whether the interaction was between AQP2 and AQP5 
homotetramers, or through the formation of AQP2/AQP5 heterotetramers (which is an 
established regulatory mechanism employed by some plant AQPs [169]). 
 
9. AQPs and cell-cell adhesion 
Adhesion of cells to one another is a vital process that paved the way for evolution of 
multicellular organisms, and allows for the formation of the varied and complex 
structures that make up the anatomy of modern animals and plants. 
There is evidence that some AQPs can perform a cell-cell adhesion function by 
forming a direct interaction with a membrane component on an adjacent cell (possibly 
another AQP molecule). This is well established for AQP0 and there is controversial 
evidence that AQP4 may also be able to perform this function. 
 
9.1 AQP0 
AQP0 (also called MIP, for lens Membrane Intrinsic Protein) is expressed primarily 
in lens fiber cells, which are cells of the eye specialized to form a tightly-packed 
transparent layer that scatters a minimal amount of incident light to support the 
function of the eye [8]. It is the most highly expressed membrane protein in these 
cells (45% by molarity of all lens fiber membrane protein in mice [170]). AQP0 
tetramers assemble into large arrays in junctional microdomains [171], which 
dynamically associate and dissociate at the array edges, with only an estimated 1% 
existing as free tetramers at a given time, measured by high-speed atomic force 
microscopy of isolated sheep lens fiber membranes [172]. 
 
Knockout studies and a variety of naturally-occurring AQP0 mutations in humans and 
mice [8] consistently show that loss of AQP0 function in the lens fiber cells causes 
cataracts, likely via loss of the tight packing of the cells required to minimize light 
scattering. It has also been suggested, based on analysis of lenses of AQP0 -/- and -/+ 
mice, that AQP0 is vital for creating the lens refractive index gradient required to 
minimize spherical aberration, via an unknown mechanism [173]. 
 
A qualitative analysis of lens fiber cell-cell adhesion in AQP0 -/- mice showed that 
transgenic expression of AQP1 in the AQP0 -/- model could not rescue fiber adhesion 
[4], nor correct lens transparency defects [174], supporting the idea that the role of 
AQP0 in lens physiology is not related to membrane water permeability. Furthermore, 
expression of AQP0 in several in vitro model systems consistently show that it is able 
to mediate cell-cell adhesion [175]. 
 
Early biophysical work on AQP0 proteoliposomes showed that AQP0 is able to 
mediate interactions with membranes containing negatively charged lipids [176]. It 
was suggested that this is due to the presence of several positively charged (and no 
negatively charged) residues in the extracellular loops A, C and E of AQP0. In human 
AQP0 this positively charged surface is made up of two arginine residues (R33 and 
R113) and three histidine residues (H40, H122 and H201).  
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A naturally occurring AQP0 mutation, R33C, showed a reduction in cell-cell adhesion 
of 18, 27 or 34% (depending on methodology) for the mutant when compared to wild-
type AQP0, despite no effect on membrane localization [177]. This suggests that 
removal of the conserved positive charge in loop A has a deleterious effect on AQP0-
mediated cell adhesion, supporting the idea of a positively charged face of AQP0 that 
forms electrostatic interactions with negatively charged molecules on an adjacent 
membrane. It is also possible that addition of the cysteine sulfhydryl group facilitates 
a novel post-translational modification that inhibits adhesive interactions.  
 
Crystallographic analyses of AQP0 suggest a different model of AQP0 mediated cell-
cell adhesion in which AQP0 molecules on adjacent cells interact with one another 
directly. An electron crystal structure of double-layered 2D AQP0 crystals suggested 
that two AQP0 molecules on adjacent membranes might be able form an interaction 
via their extracellular loops, primarily mediated by proline residues [178]. Follow-up 
work showed that the way in which the AQP0 extracellular domains (ECDs) interact 
in these crystals is strongly dependent on the headgroup of co-crystallized lipids 
[179]. It has been suggested, based on comparison of the electron structure with a 3D 
X-ray structure of full-length AQP0 [180], that a conformational change in loop A 
induced by proteolytic truncation of the C-terminus (which is observed in vivo [8]) 
could facilitate direct binding of AQP0 molecules to one another [181]. However 
biochemical analysis showed that truncation of either the N- or C-terminus has no 
effect on the adhesion properties of AQP0 [182]. 
 
Experiments with a fusion protein consisting of the sequences of the three 
extracellular loops of AQP0 fused directly adjacent to one another showed that this 
protein was able to competitively inhibit AQP0 mediated cell-cell adhesion [183]. 
Given the relative location of the three loops in the AQP0 fold and the lack of 
transmembrane anchoring in the fusion protein, it is very unlikely that this protein is 
structurally similar to the ECD of intact AQP0. The fact that, despite this, it functions 
as an inhibitor of AQP0 mediated cell-cell adhesion does not support the idea of the 
adhesion being mediated by direct AQP0-AQP0 binding, which would depend on the 
structure of the ECD. It does, however, support the idea of mediation via an (structure 
independent) electrostatic interaction between the positively charged AQP0 ECD and 
a negatively charged membrane component on an adjacent cell. 
 
 
9.2 AQP4 
AQP4 is a water-selective AQP primarily expressed in glial cells (astrocytes and 
retinal Müller cells) of the central nervous system and the basolateral membranes of 
kidney collecting duct cells [155]. AQP4 exists in two major isoforms (although there 
is emerging evidence of further isoforms [184]). These are the long (323 amino acids) 
M1 isoform and the shorter (301 amino acids) M23 isoform, named for the position of 
the N-terminal methionine. Similarly to AQP0, the M23 isoform of AQP4 is able to 
form large supramolecular arrays (termed OAPs for Orthogonal Array of Particles). 
 
Electron crystallography of double-layered 2D AQP4-M23 crystals suggested that 
AQP4 molecules on adjacent cells could interact via their ECDs in a similar way to 
that suggested for AQP0, again mediated by interaction between proline residues 
[185]. In the same study, AQP4-M23 was shown to facilitate cell-cell interactions 
between adhesion-deficient mouse fibroblasts. This result was corroborated in a 
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similar experimental system, and it was shown that the adhesion generated by AQP4-
M23 was considerably weaker than that by AQP0. Furthermore, AQP4-M1 was 
shown not to facilitate adhesion [175]. Another study in the same experimental 
system failed to reproduce these results and furthermore failed to find AQP4-
mediated adhesion in primary mouse glia or AQP4-transfected CHO cell membrane 
vesicles [186]. 
 
Transfection of AQP4-M23 into a glioblastoma cell line (D54, which lacks 
endogenous AQP4 expression) increased adhesion of the cells to collagen, 
fibronectin, laminin, and vitronectin substrates [187]. Clearly this is not due to any 
potential cell-cell adhesion properties of AQP4 and the lack of substrate specificity 
makes this a difficult result to interpret. However, AQP4-M23 was shown to 
preferentially localize to membrane-substrate adhesion sites [188], so it is possible 
that AQP4-M23 could facilitate aggregation or localization of adhesion molecules, 
thereby having an indirect effect on cellular adhesion, both to other cells and to 
basement membrane components.  
 
10. Conclusion 
Mammalian AQPs are primarily known as facilitators of physiological processes 
through bi-directional, passive water transport. We have reviewed evidence 
demonstrating that this is far from all they do. AQPs facilitate physiological processes 
by mediating the diffusion of small, neutral solutes. This is best understood for AQP-
mediated glycerol transport that facilitates glycerol metabolism, triglyceride cycling 
and skin hydration. AQPs also have a role in cell volume regulation and it is 
becoming increasingly clear that this role can extend beyond simply acting as a 
passive water pore and may involve AQP-mediated signal transduction, although the 
mechanisms that may be involved in this are not well understood. Many cell types 
express several different members of the AQP family and there is emerging evidence 
that the different members can interact with one another either physically or 
functionally. The involvement of AQPs in human physiology and cellular 
homeostasis goes far beyond their acting as simple water pores with implications for a 
range of physiological processes and pathophysiological conditions. 
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Figure 1 – structure of AQPs exemplified by human AQP4. (A) AQPs have six 
bilayer-spanning helices and two helix-forming loops. These loops contain the 
conserved NPA motifs (coloured blue). The residues forming the arginine/aromatic 
region thought to be important for solute selectivity are coloured yellow. (B) 
Simulation snapshot of AQP4 embedded in a POPC bilayer. Phosphorus atoms in the 
lipid headgroups are coloured green and the fatty acid tails are yellow. Visualized 
using VMD[189].  
